IPCALAB

What IPCA Laboratories promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 21 tracked 3 delivered 3 missed 15 open
  • R&D Spend as % of Revenue went quiet said Q3 FY25 Promised: Move to around 4% Q1 FY27: No update provided on R&D spend as a percentage of revenue. Only capex for R&D facilities mentioned.
  • ANDA Filings (Ipca) revised down said Q3 FY25 Promised: 5 to 6 filings every year Q1 FY27: Guidance revised down to '4 to 5 filings will happen every year for Ipca' from the original 5-6.
  • Consolidated EBITDA Margin delivered said Q4 FY25 Promised: Improve by around 1% to around 20% for FY26 Q4 FY26: FY26 consolidated EBITDA margin reported at 20.72%, meeting the ~20% guidance.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 21 tracked commitments for IPCA Laboratories — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens